TetraKit Technologies
Copenhagen · Founded 2021
About TetraKit Technologies
TetraKit Technologies is a click chemistry-based radiochemical platform developing therapeutics for metastatic cancer. The company offers targeted radionuclide therapy and nuclear imaging platform for the diagnosis of cancer and provides offers radiopharmaceuticals fluorine-18 and astatine-211 as radionuclide pairs for PET imaging and targeted alpha-radionuclide therapy. It was founded in 2021 and is headquartered in Copenhagen, Denmark.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $548.4K
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: https://tetrakit.com/
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tetrakit-technologies-120453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.